US Prescription Drug Spending to Top $560bn in 2026

Original Article by Annika Inampudi | Bloomberg | 24 June 2026

US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.

US Prescription Drug Spending to Top $560bn in 2026

US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here